心肌纤维化对TAVI术后左室重构、恢复及结局的影响:不同血流动力学亚型分析
AIMS: Myocardial fibrosis (MF) might represent a key player in pathophysiology of heart failure in aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) remodelling, recovery, and mortality after transcatheter aortic valve implantation (TAVI) in different A…
要点
- 低EF低跨瓣压差AS亚型心肌纤维化最重,正常EF高跨瓣压差最轻。
- MF+患者TAVI术后左室几何和功能恢复正常延迟,但仍有逆重构和临床改善。
- MF+是TAVI术后心血管死亡的独立预测因子(HR 27.4)。
核心结论
- 组织学心肌纤维化与AS相关病理性左室重构相关,并独立预测TAVI术后心血管死亡。
研究设计与样本
- 基线、术后6个月、1年、2年进行临床和超声心动图随访。
主要发现
- MF负担在AS亚型间差异显著:低EF低跨瓣压差组29.5±26.4% vs 正常EF高跨瓣压差组13.5±16.1%,P=0.003。
- MF+与基线更差的左室功能、更重的病理性左室重构和更明显的临床心衰相关。
- TAVI术后MF+与左室几何和功能正常化延迟相关,但不排除逆重构和临床改善。
- 随访平均11个月,22例死亡,其中心血管死亡14例(9例与心律失常相关),13例心血管死亡发生于MF+患者。
关键数值与推荐
- 心肌纤维化以纤维化面积占组织总面积百分比≥11%定义为MF+。
- AS亚型分组基于EF和跨瓣压差。
临床怎么用
- TAVI术前评估心肌纤维化可能有助于识别术后心血管死亡高风险患者。
- 对MF+患者应加强术后随访和心衰管理,尽管其仍可能从TAVI中获得逆重构和临床改善。
局限性
- 单中心前瞻性研究,结果需更大样本验证。
- 心肌纤维化评估仅基于活检组织学,未与无创影像学对比。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Myocardial fibrosis (MF) might represent a key player in pathophysiology of heart failure in aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) remodelling, recovery, and mortality after transcatheter aortic valve implantation (TAVI) in different AS subtypes. METHODS AND RESULTS: One hundred patients with severe AS were prospectively characterized clinically and echocardiographically at baseline (BL), 6 months, 1 year, and 2 years following TAVI. Left ventricular biopsies were harvested after valve deployment. Myocardial fibrosis was assessed after Masson's trichrome staining, and fibrotic area was calculated as percentage of total tissue area. Patients were stratified according to MF above (MF+) or below (MF-) median percentage MF (≥11% or <11%). Myocardial fibrosis burden differed significantly between AS subtypes, with highest levels in low ejection fraction (EF), low-gradient AS and lowest levels in normal EF, high-gradient AS (29.5 ± 26.4% vs. 13.5 ± 16.1%, P = 0.003). In the entire cohort, MF+ was significantly associated with poorer LV function, higher extent of pathological LV remodelling, and more pronounced clinical heart failure at BL. After TAVI, MF+ was associated with a delay in normalization of LV geometry and function but not per se with absence of reverse remodelling and clinical improvement. However, 22 patients died during follow-up (mean, 11 months), and 14 deaths were classified as cardiovascular (CV) (n = 9 arrhythmia-associated). Importantly, 13 of 14 CV deaths occurred in MF+ patients (CV mortality 26.5% in MF+ vs. 2% in MF- patients, P = 0.0003). Multivariate analysis identified MF+ as independent predictor of CV mortality [hazard ratio (HR) 27.4 (2.0-369), P = 0.01]. CONCLUSION: Histological MF is associated with AS-related pathological LV remodelling and independently predicts CV mortality after TAVI.
引用
- Puls M, Beuthner BE, Topci R, et al. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis. Eur Heart J. 2020. PMID: 32049275. doi:10.1093/eurheartj/ehaa033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。